Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

'Pharmacy First could damage the already fragile workforce situation, if not introduced properly'

'Pharmacy First could damage the already fragile workforce situation, if not introduced properly'

Only 4% pharmacists surveyed said that they had confidence the sector could deliver the PFS alongside the existing workload 

Many frontline pharmacists have raised concerns about the hurried launch of Pharmacy First Service (PFS) in England amidst the many challenges currently facing community pharmacy, especially inadequate staffing.


To understand the reality of the sector’s preparedness for the introduction of the scheme, the Pharmacists' Defence Association (PDA) recently conducted a survey.

Over 3,500 employed and locum pharmacists who work in England’s community pharmacies participated in the survey, which ran between 5 and 14 January.

After reviewing all the data and comments, it was found that nearly 70 per cent of respondents strongly agreed/agreed with the principle of Pharmacy First.

While 84 per cent agreed that the scheme could improve patient care, up to 77 per cent respondents stated that it could improve professional fulfilment for pharmacists.

However, 87 per cent of the participants strongly agreed/agreed that the new service could damage the already “fragile” workforce situation, if it is not introduced or resourced properly.

Overall, 66 per cent of respondents said that they were not confident that their pharmacy would be able to deliver PFS on 31 January given the current workload, and nearly 30 per cent were unsure they can do it.

Only four per cent of the pharmacists surveyed expressed confidence that the sector could deliver the PFS in addition to the existing workload on 31 January.

Many respondents were apprehensive that the additional demand for Pharmacy First consultations will result in an increase in their exposure to violence and abuse from members of the public when their expectations are not met.

PDA suggests changes to the introduction of PFS

The association shared the survey results to the NHS England and the Department of Health and Social Care (DHSC) in a meeting on 17 January, suggesting changes to the introduction of the scheme to support the patient and pharmacist experience in the early stages.

The PDA asked the CPhO for NHS England and senior DHSC officials to make the launch of the seven new services to be more gradual, so that the sector gets more time to prepare and, in this way, their exposure to abuse will be reduced.

Shortage of funding for community pharmacy has led to a reduction in pharmacy staffing levels, the association said, and suggested that “this vicious cycle needs to be broken and reversed if pharmacy is to reach its full potential.”

Community pharmacies will be provided funding for extra staff needed for delivery of Pharmacy First.

But the PDA argued that use of this funding is not being monitored by NHS England, and pharmacists have seen little in the way of extra resources being made available.

It has also warned of the severe staffing level shortages situation and its likely impact upon the safety of patients and pharmacists.

Despite the discussion with NHS England and DHSC, there hasn’t been any changes to the national launch plans of the scheme, which is scheduled to begin on 31 January 2024.

More For You

RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less
Astrazeneca Office Building  Outlook

British Medical Journal has found data discrepancy during the crucial clinical trials of AstraZeneca's heart drug ticagrelor.

iStock

Top medics question trials of AstraZeneca's anti-clotting pill

The effectiveness of anti-clotting pill ticagrelor is now under a cloud, with some experts claiming that AstraZeneca misreported data when the trials were conducted more than a decade ago.

Sold as Brilinta, the pill was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack, and the generic versions of the drug are scheduled for this year.

Keep ReadingShow less
Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

iStock

Pensions Ombudsman probing Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

According to the Pharmacists' Defence Association (PDA), the ombudsman has decided to take a ‘lead case’ approach, as several members have been affected by the issue.

Keep ReadingShow less
23andMe

More than 150,000 UK residents had their personal information taken by hackers during a data breach in 2023.

iStock

UK watchdog fines 23andMe £2.31m for data breach

Genetic testing firm 23andMe has been fined £2.31 million by a UK watchdog over a 2023 data breach, when the personal information of seven million people across the world was stolen.

The Information Commissioner's Office (ICO) said the California-based company, which later filed for bankruptcy, failed to put adequate measures in place to secure sensitive user data.

Keep ReadingShow less